Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/11/2012CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells
09/11/2012CA2326407C Retroviral vectors including modified envelope escort proteins
09/10/2012CA2733956A1 Compositions and methods for modulating circadian synchronization
09/08/2012CA2825519A1 Pyrrole derivatives used as modulators of alpha7 nachr
09/08/2012CA2771189A1 Novel dihydro-oxazolobenzodiazepinon derivatives, processes for their preparation and pharmaceutical compositions containing them
09/07/2012WO2012119151A2 Method and apparatus for alcohol administration
09/07/2012WO2012119103A2 Compositions and methods for mobilization of stem cells
09/07/2012WO2012119045A2 Compositions and uses thereof to ameliorate pain
09/07/2012WO2012118983A2 Botanical formulation derived from birch bark
09/07/2012WO2012118796A1 Compositions for controlling neuronal outgrowth
09/07/2012WO2012118498A1 Compounds and methods for the treatment of pain and other disorders
09/07/2012WO2012118172A1 Drug for improving central functions during pain
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/07/2012WO2012117373A1 Genetically modified muscle cells which express neurotrophic factors
09/07/2012WO2012117334A1 Mglur5 positive allosteric modulators for use in the treatment phelan-mcdermid syndrome
09/07/2012WO2012117219A1 Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereof
09/07/2012WO2012117062A1 Piperidinyl benzoimidazole derivatives as mpges-1 inihibitors
09/07/2012WO2012117027A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/07/2012WO2012117001A1 Novel benzodioxole piperidine compounds
09/07/2012WO2012116965A1 Bridged piperidine derivatives
09/07/2012WO2012116859A1 Use of aldosterone receptor antagonists for treating female sexual dysfunction and migraine
09/07/2012WO2012116586A1 2-aminothiazole derivative, preparation method, and use
09/07/2012WO2012116577A1 Chlorogenic acid analogue, preparation process and use thereof
09/07/2012WO2012116440A1 Benzimidazole inhibitors of the sodium channel
09/07/2012WO2012116415A1 Novel small-molecules as therapeutics
09/07/2012WO2012116410A1 Methods of treating a disease or condition of the central nervous system
09/07/2012WO2012093787A3 Composition for activating gabaa benzodiazepine receptor and composition for anxiety alleviation, convulsion reduction, sedation and sleep induction and improvement containing phloroglucinol, phlorotannin or brown algae extract
09/07/2012WO2012091571A3 Combination of components for the prevention and treatment of frailty
09/07/2012WO2012077932A3 Novel pyrazole pyridine derivative or pharmaceutically acceptable salts thereof, method for producing same, and pharmaceutical composition including same
09/07/2012WO2012076907A3 Dosage form
09/07/2012WO2012059443A3 Novel neurotrypsin inhibitors
09/07/2012CA2828831A1 Compounds and methods for the treatment of pain and other disorders
09/07/2012CA2828801A1 2-aminothiazole derivative, preparation method, and use
09/07/2012CA2828780A1 Novel small-molecules as therapeutics
09/07/2012CA2828765A1 Baclofen and acamprosate based therapy of neurological disorders
09/07/2012CA2828764A1 Anti-amyloid compounds and methods
09/07/2012CA2828763A1 New compositions for treating neurological disorders
09/07/2012CA2828524A1 Histone deacetylase inhibitors
09/07/2012CA2828456A1 Benzimidazole inhibitors of the sodium channel
09/07/2012CA2824360A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/07/2012CA2824239A1 Bridged piperidine derivatives
09/07/2012CA2823480A1 Novel benzodioxole piperidine compounds
09/06/2012US20120226245 Transdermally absorbable preparation
09/06/2012US20120225951 Parenteral Administration of Tapentadol
09/06/2012US20120225950 Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
09/06/2012US20120225949 Compositions and methods for treating bipolar disorder
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/06/2012US20120225938 Method for treating central nervous system disorders
09/06/2012US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists
09/06/2012US20120225927 Compositions and methods for inhibiting expression of transthyretin
09/06/2012US20120225922 Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
09/06/2012US20120225916 Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
09/06/2012US20120225906 Piperidine renin inhibitors
09/06/2012US20120225904 New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives
09/06/2012US20120225902 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
09/06/2012US20120225901 Dosage form containing oxycodone and naloxone
09/06/2012US20120225893 Combination of an antipsychotic and an anti-inflammatory agent
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/06/2012US20120225885 Imidazole derivatives and methods of use thereof
09/06/2012US20120225884 Bridged piperidine derivatives
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225882 Selective hydroxamate based mmp inhibitors
09/06/2012US20120225881 Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hyrdroxy-2-amino-propionic acid amides and related compounds
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225878 Compounds
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225873 Compounds for alzheimer's disease
09/06/2012US20120225868 Novel benzodioxole piperidine compounds
09/06/2012US20120225865 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
09/06/2012US20120225864 Methods and Compositions for Modulating Tau Levels
09/06/2012US20120225858 1,4 thiazepines/sulfones as bace1 and/or bace2 inhibitors
09/06/2012US20120225857 Mst1 kinase inhibitors and methods of their use
09/06/2012US20120225855 Triazolopyridine jak inhibitor compounds and methods
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
09/06/2012US20120225853 Hormone replacement therapy and depression
09/06/2012US20120225848 Antagonists of GABA-B Receptors to Enhance Neuronal Function, Learning and Memory
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/06/2012US20120225844 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
09/06/2012US20120225833 Composition for treating mental health disorders
09/06/2012US20120225823 Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction
09/06/2012US20120225822 Peptides for the treatment of oxidative stress related disorders
09/06/2012US20120225821 Composition for preventing or treating a spinal cord injury
09/06/2012US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient
09/06/2012US20120225482 Mammalian cx3c chemokine antibodies
09/06/2012US20120225478 Anti-amyloid beta antibodies and their use
09/06/2012US20120225134 Methods and compositions for the treatment and prevention of hypoglycemia and related disorders
09/06/2012US20120225133 Use of an agent that restores tissue perfusion and oxygenation
09/06/2012US20120225122 Abuse-Resistant Formulations
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225112 Method and Apparatus for Alcohol Administration
09/06/2012US20120225100 Articlea and processes for Making a Porous Disintegratable Solid Substrate for Personal Health Care Applications
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225096 Immunomodulation using placental stem cells
09/06/2012US20120225084 Klf family members regulate intrinsic axon regeneration ability
09/06/2012US20120225075 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
09/06/2012US20120225070 Methods for treating progressive multiple sclerosis
09/06/2012US20120225067 Composition and Method for Mediating an Immune Response
09/06/2012US20120225065 Anti-human il-21 monoclonal antibodies
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 1833